Skip to content

To evaluate the efficacy of Jeevantyadi Ghrita in Presbyopia

A Randomised Controlled Trial to assess the Efficacy of Jeevantyadi Ghrita Aschyotana and Jeevantyadi Ghrita oral Intake in the Management of Timira w.s.r to Presbyopia

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/02/049750
Enrollment
30
Registered
2023-02-15
Start date
Unknown
Completion date
Unknown
Last updated
2023-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H524- Presbyopia

Interventions

None listed

Sponsors

National Institute of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients willing to participate in the trial by taking written informed consent. Patients who are 35 years of age and from either sex. Patients having specific symptoms of prathama and dwitiya patalagata timira. Early to moderate presbyopia determined by screening monocular best-corrected distant visual acuity (VA)

Exclusion criteria

Exclusion criteria: Patient with any active ocular infection. Patients with preauricular lymphadenopathy. Patients with moderate to severe dry eye . Patients with any abnormal lens findings. Patients having intraocular pressure (IOP) that is less than 5 millimeters of mercury (mmHg) or greater than 22 mmHg in either eye. prior diagnosis of ocular hypertension or glaucoma or currently being treated with any type of topical IOP lowering (glaucoma) medication Patients who have abnormal findings on dilated fundus examination in either eye. Patients having known history of retinal detachment or clinically significant retinal disease in either eye. Patients who have had surgical intervention (ocular or systemic) within 6 months prior to visit. Patients with severe systemic illnesses. Planned intra ocular or extra ocular surgery in either eye during study period

Design outcomes

Primary

MeasureTime frame
Change in amplitude of accommodationTimepoint: 30th day

Secondary

MeasureTime frame
Change in Timira Presbyopia Symptom Score (TPSS) Timepoint: 30 days

Countries

India

Contacts

Public ContactDr Prabhakar Vardhan

National Institute of Ayurveda

shalakya007@gmail.com9461065960

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026